High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis
Abstract Cryptococcus spp., the causative agents of cryptococcosis, are responsible for deaths of hundreds of thousands of people every year worldwide. The drawbacks of available therapeutic options are aggravated by the increased resistance of yeast to the drugs, resulting in inefficient therapy. A...
Guardado en:
Autores principales: | Julliana Ribeiro Alves Santos, Noelly Queiroz Ribeiro, Rafael Wesley Bastos, Rodrigo Assunção Holanda, Letícia Chagas Silva, Estela Rezende Queiroz, Daniel Assis Santos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/99c2bed22fe54969917ab9ebbd1e7e52 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B
por: Jakub Suchodolski, et al.
Publicado: (2021) -
Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study
por: Nada WM, et al.
Publicado: (2017) -
Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance
por: William Hope, et al.
Publicado: (2019) -
In vitro and in vivo analysis of monotherapy and dual therapy with ethyl caffeate and fluconazole on virulence factors of Candida albicans and systemic candidiasis
por: Tianming Wang, et al.
Publicado: (2021) -
Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B
por: Do-Yeon Cho, et al.
Publicado: (2017)